Surrozen (SRZN) Change in Receivables (2024 - 2026)
Surrozen (SRZN) recorded quarterly Change in Receivables of -$208000.0 in Q1 2026, up 89.8% quarter-over-quarter from -$2.0 million in Q4 2025.
Surrozen (SRZN) Change in Receivables (2024 - 2026) Analysis & Trends
Surrozen's Change in Receivables history runs 3 years deep, the most recent figure standing at -$208000.0 for Q1 2026.
- In Q1 2026, Change in Receivables changed N/A year-over-year to -$208000.0; the TTM figure through Mar 2026 stood at -$2.2 million (down 547.61% YoY), while the FY2025 annual figure was -$2.0 million, down 506.18% from the prior year.
- Change in Receivables was -$208000.0 for Q1 2026 at Surrozen, up from -$2.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $502000.0 in Q4 2024 to a low of -$2.0 million in Q4 2025.
- Historically, Change in Receivables has averaged -$349000.0 across 3 years, with a median of -$208000.0 in 2026.
- Biggest YoY gain for Change in Receivables was 506.18% in 2025; the steepest drop was 506.18% in 2025.
- A 3-year view of Change in Receivables shows it stood at $502000.0 in 2024, then tumbled by 506.18% to -$2.0 million in 2025, then jumped by 89.8% to -$208000.0 in 2026.
- The last three Change in Receivables figures came in at -$208000.0 (Q1 2026), -$2.0 million (Q4 2025), and $250000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | -208,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -208,000.00 |
| Mar 31, 2026 | -208,000.00 |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Sep 30, 2025 | 250,000.00 |
| Sep 30, 2025 | 250,000.00 |
| Jun 30, 2025 | -250,000.00 |
| Jun 30, 2025 | -250,000.00 |
| Dec 31, 2024 | 502,000.00 |
| Dec 31, 2024 | 502,000.00 |